Cyclacel Pharmaceuticals Inc
F:UXI4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cyclacel Pharmaceuticals Inc
F:UXI4
|
US |
|
P
|
Proactis SA
PAR:PROAC
|
FR |
|
M
|
Multi Retail Group Ltd
TASE:MRG
|
IL |
|
C
|
Carindale Property Trust
ASX:CDP
|
AU |
|
C
|
C3 Metals Inc
OTC:CUAUF
|
CA |
|
F
|
Firm Capital Mortgage Investment Corp
F:74X
|
CA |
|
R
|
Radium Resources Corp
OTC:RADR
|
CA |
|
Dropsuite Ltd
ASX:DSE
|
AU |
|
Adrad Holdings Ltd
ASX:AHL
|
AU |
|
S
|
Scodix Ltd
TASE:SCDX
|
IL |
|
Mount Logan Capital Inc
OTC:PYCFF
|
CA |
|
Investcorp Europe Acquisition Corp I
OTC:IVCBF
|
KY |
|
Retail Food Group Ltd
F:JUU
|
AU |
|
Yotta Acquisition Corp
OTC:YOTA
|
US |
|
Australian Gold and Copper Ltd
ASX:AGC
|
AU |
|
P
|
Prestige Cars International Inc
OTC:PREC
|
US |
|
Ayala Corp
OTC:AYYLF
|
PH |
|
Biotechnology Assets SA
MAD:BST
|
ES |
|
Edreams Odigeo SA
LSE:0QS9
|
ES |
|
T
|
T2 Biosystems Inc
F:3T2
|
US |
Bankruptcy Probability
Cyclacel Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cyclacel Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
|
14.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cyclacel Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cyclacel Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
